Aadi Bioscience Transforms With In-Licensing Of Novel ADC Portfolio, $100 Million Sale Of FYARRO® And $100 Million PIPE Financing. Aadi Enters into Exclusive License for Three-Asset ADC Portfolio ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results